Open original FDA record ↗Recall record
- FDA identifier
- Z-0624-2024
- Company in FDA record
- Randox Laboratories Ltd.
- FDA classification date
- Jan 2, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
A decrease in the reactivity of HSV Type 1/2 lgM in the Serology ToRCH lgM Positive Control when tested on the DiaSorin Liaison XL.
Source facts
- Action
- Randox issued Urgent Medical Device Correction Letter on 11/6/23 to the US Distributor Randox Laboratories-US, Ltd. , Kearneysville, West Virginia, for issuance to the user level. Letter states reason for recall, health risk and action to take: As the control material is still testing positive for HSV Type 1/2 lgM, there is no risk to health. If the control did test negative for this analyte, the affected run should be discarded, and the samples re-analysed. Action to be taken: " Discuss the contents of this notice with your Medical Director. " Complete and return the response form 12187-QA to technical.services@randox.com within five working days. " Please discard all copies of the IFU and download the latest version from www.randox.com.alth risk and action to take: (
- Initiated
- 2023-11-06
- Root cause
- Process control
- Distribution
- NY, WV
- Recall number
- Z-0624-2024
- Recall status
- Open, Classified
- CDRH record ID
- 204695
- FDA classified
- 2024-01-02
- Recall event number
- 93543